Format

Send to

Choose Destination
Lancet Diabetes Endocrinol. 2018 Sep;6(9):686-687. doi: 10.1016/S2213-8587(18)30213-4.

Radioactive iodine ablation in low-risk thyroid cancer - Authors' reply.

Author information

1
Departments of Nuclear Medicine and Endocrine Oncology, Gustave Roussy Institute, 94805 Paris, France; Paris-Saclay University, France.
2
Biostatistics and Epidemiology, Gustave Roussy Institute, 94805 Paris, France; Paris-Saclay University, France. Electronic address: isabelle.borget@gustaveroussy.fr.
PMID:
30143188
DOI:
10.1016/S2213-8587(18)30213-4
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center